Bioorganic and Medicinal Chemistry Letters p. 3603 - 3608 (1998)
Update date:2022-07-31
Topics:
Adang, Anton E.P.
Lucas, Hans
De Man, Adrianus P.A.
Engh, Richard A.
Grootenhuis, Peter D.J.
Replacement of the noragmatine group in thrombin inhibitors with a β- alanyl-guanidine group resulted in a nearly equipotent and more selective compound 8 despite the fact that the pK(a) of this P1 moiety is five orders of magnitude lower. Furt
View MoreContact:021-50278900
Address:No.6,Room 201 ,Lane 299,bisheng road ,shanghai ,china
Hebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
Tianjin Ingenochem Technology Co.,Ltd
Contact:+86-22-23677060
Address:Hitech Green Industry Park K2-9-602, Nankai district
Ningbo Tide Imp. & Exp. Co., Ltd.
Contact:+86-571-8993 7933; +86-571-8993 6453
Address:7/F Anno Domini Building, Tower South, 8 Qiu Shi Road,Hangzhou,China.
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Doi:10.1002/anie.202004769
(2020)Doi:10.1016/S0040-4020(01)97854-8
(1970)Doi:10.1002/mrc.1270040610
(1972)Doi:10.1246/cl.2008.362
(2008)Doi:10.1021/jm970343g
(1997)Doi:10.1002/hlca.19960790720
(1996)
